MUMBAI Feb 10 India's Wockhardt Ltd
reported a 29 percent drop in quarterly net profit, hit by a
fall in sales after the U.S. health regulator banned two of the
drugmaker's plants from exporting products to the United States
- its largest market.
In November, the U.S. Food and Drug Administration issued an
import alert, effectively a ban, against Wockhardt's Chikalthana
plant in western India. The FDA had imposed a ban on the
company's Waluj plant in May.
Wockhardt's net profit in the third quarter fell to 3.04
billion rupees ($48.75 million) from 4.28 billion rupees a year
earlier, the company said in a statement late on Sunday. Total
sales dropped 14 percent to 12.37 billion rupees.
The company's U.S. business, which accounts for 44 percent
of revenue, fell 30 percent in the quarter.
($1 = 62.3600 Indian rupees)
(Reporting by Sumeet Chatterjee; Editing by Supriya Kurane)